🌱 KidneyEnergy.com

← brief for 2026-10-13 · Slowing decline

Effects of Sodium-Glucose Cotransporter Type 2 Inhibitors on Residual Kidney Function in Patients Undergoing Incremental Hemodialysis: A Two-Center, Retrospective, Exploratory Cohort Study

Article C Peer reviewed Observational

Key takeaways

This study looked at people on dialysis who took a type of diabetes drug called an SGLT-2 inhibitor. It tracked how much kidney function they kept over 12 months. Because it was an observational study, it shows a link but not proof that the drug caused the change.

Who did this work

Jose Carlos de la Flor (Universidad de Alcalá) · Elena Jiménez Mayor · Avinash Chandu Nanwani · Celia Rodríguez Tudero (Universidad de Salamanca) · Francisco Valga (Universidad Fernando Pessoa Canarias) · Esperanza Moral Berrio (Hospital General Universitario de Ciudad Real) · Javier Deira (Hospital San Pedro de Alcántara) · Jesús Hernández Vaquero (Hospital Central de la Defensa Gómez Ulla) · Gabriel de Arriba (Universidad de Alcalá)

Source

Article · OpenAlex, CKD works · 2026-10-12
https://doi.org/10.3390/medicina62101972